- By the end of 2027, Cretex Medical expects to employ approximately 100 people in Costa Rica, doubling its local workforce through new hires in production and support roles.
Cartago, Costa Rica, and Elk River, Minnesota (November 18, 2026). Cretex Medical, a manufacturing partner to medical device companies worldwide, officially inaugurated its manufacturing facility in Costa Rica following an investment of more than $20 million. Located in La Lima Free Zone in Cartago, the company currently employs approximately 50 people and expects to double its local workforce to 100 employees by the end of 2027.
The facility began operations in January 2026 and serves as a strategic platform to support the company’s global growth. Looking ahead, Cretex Medical plans to expand its facilities and grow its workforce to more than 300 employees by 2030, reaffirming its long-term commitment to Costa Rica.
Cretex Medical’s Costa Rica operations currently focus on value-added assembly, supported by key vertically integrated manufacturing capabilities, including machining, molding, laser processing, kitting, sterile packaging, and catheter assembly technologies. This model helps customers simplify their supply chains, optimize logistics, and accelerate the delivery of innovative products to patients worldwide.
“Costa Rica represents a major milestone in Cretex Medical’s long-term growth strategy and strengthens our ability to support our customers wherever they operate around the world,” stated Nick Morrison, Chief Operating Officer (COO) of Cretex Companies. “The country’s strong medical technology ecosystem, exceptional talent, and strategic proximity to many of our customers make it an ideal location to expand our manufacturing footprint. This investment allows us to offer greater capacity, strengthen supply chain resilience, and continue delivering the high-quality solutions our customers rely on.”
The facility, spanning more than 6,000 square meters, includes dedicated manufacturing areas, ISO Class 7 and Class 8 cleanrooms, offices, and employee wellness spaces. The site also has the capacity to expand to approximately 12,500 square meters in the future.
As part of this process, the Costa Rica operation obtained ISO 13485 certification in September 2025, the international quality management standard for medical device manufacturing. Shortly afterward, Cretex Medical completed the acquisition of Atemisa Precision, an award-winning local manufacturer, further strengthening its ability to support critical tooling and devices used in manufacturing processes in Costa Rica.
Julio Lizano, General Manager of Cretex Medical Costa Rica, highlighted: “Our team in Costa Rica has made extraordinary progress in a short period of time, from building a world-class facility to successfully launching production. We are proud to contribute to one of the most dynamic medical device manufacturing ecosystems in the world, while creating quality employment opportunities and developing advanced manufacturing capabilities that will continue to grow in the coming years.”
The decision to establish operations in Costa Rica was driven by several key strategic factors, including the country’s highly skilled workforce, well-established medical device industry, robust business infrastructure, and a shared people-first, customer-focused culture. Costa Rica is globally recognized as a leading medical technology manufacturing hub and continues to attract investment from major global healthcare corporations.
“Cretex Medical’s decision to establish operations in Costa Rica further strengthens our country’s position as a strategic destination for advanced manufacturing and reflects the conditions we have developed to attract high-value production operations. This project reinforces our participation in global value chains and reaffirms Costa Rica’s potential to continue advancing toward increasingly sophisticated manufacturing and technological activities. We are pleased to support companies like Cretex Medical as they develop their operations and pursue their growth plans from Costa Rica into international markets,” stated Arianna Arce, Acting Minister of Foreign Trade of Costa Rica.
“Cretex Medical’s investment demonstrates its confidence in the capabilities Costa Rica has developed in medical technology manufacturing, as well as in its skilled workforce and local suppliers. Its operations bring specialized knowledge and processes to the ecosystem and will create new employment opportunities for more than 300 people in the coming years, in an industry that develops solutions for patients around the world. Projects like this expand our manufacturing base and enable us to continue attracting high-value investments,” added Laura López, CEO of the Trade and Investment Promotion Agency of Costa Rica (PROCOMER).
Globally, Cretex Medical manufactures more than one million medical device components every day and supports leading original equipment manufacturers (OEMs) in the medical industry across markets including interventional therapies, orthopedics, minimally invasive surgery, robotics, and active implantable devices.
As part of its expansion plans, the Costa Rica facility is expected to incorporate additional vertically integrated technologies as it develops into a strategic manufacturing center for global customers, supported by the business ecosystem, specialized infrastructure, and access to skilled technical talent available at La Lima Free Zone.
Individuals interested in joining Cretex Medical’s growing team in Costa Rica can learn more about available job opportunities at www.cretex.com/contact-us-cretex-medical-costa-rica/ or submit their résumés to the recruitment email address: [email protected].